Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 447, 513 (31 May 2007) | doi:10.1038/447513a; Published online 30 May 2007
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
- More Challenges
- Powered by:
nature jobs
Flash Animator
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Senior Executive- Finance Corporate Office
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Man on a mission
Meredith Wadman
Abstract
A look at the world of Steven Nissen, the cardiologist who raised worries about Vioxx and Avandia.
It isn't every clinical scientist who in the space of a month sends a major drug company's stock plummeting, is invited to testify at Congress and is crowned one of the world's 100 most influential people by Time magazine. But then, they aren't Steven Nissen, the cardiologist who last week fingered the diabetes drug Avandia as carrying a possible risk of heart attacks (see Weighing up the evidence).
To read this story in full you will need to login or make a payment (see right).
